Showing results (331-340 of 1,003) with videos related to
Sort By:
Pageof 101
Cardiovascular Therapeutics|November 28, 2008
Nonequivalence of inhaled and nebulized salbutamol in the assessment of endothelial dysfunctionRoy L Soiza, M Yaqoob Bhat, Mike A Crilly, et al.Cardiovascular Therapeutics|November 28, 2008
Role of adenosine antagonism in the cardiorenal syndromeMustafa M Dohadwala, Michael M GivertzCardiovascular Therapeutics|June 27, 2009
Prescribing statins to patients with nonalcoholic fatty liver disease: real cardiovascular benefits outweigh theoretical hepatotoxic riskP Riley, M Al Bakir, J O'Donohue, et al.Cardiovascular Therapeutics|February 12, 2009
Cardiac functional reserve is diminished in growth hormone-deficient adultsRobert Moisey, Steve Orme, Diane Barker, et al.Cardiovascular Therapeutics|October 15, 2013
Practical considerations in the use of novel oral anticoagulants for stroke prevention in nonvalvular atrial fibrillationSteven DeitelzweigCardiovascular Therapeutics|April 8, 2010
Natural antioxidants and hypertension: promise and challengesTinoy J Kizhakekuttu, Michael E WidlanskyCardiovascular Therapeutics|April 8, 2010
STATIN-D study: comparison of the influences of rosuvastatin and fluvastatin treatment on the levels of 25 hydroxyvitamin DDerun Taner Ertugrul, Bunyamin Yavuz, Hicran Cil, et al.Cardiovascular Therapeutics|April 8, 2010
Surgical Maze procedure as a treatment for atrial fibrillation: a meta-analysis of randomized controlled trialsMelissa H Kong, Renato D Lopes, Jonathan P Piccini, et al.Cardiovascular Therapeutics|April 8, 2010
Chinese yellow wine and red wine inhibit matrix metalloproteinase-2 and improve atherosclerotic plaque in LDL receptor knockout miceHangyuan Guo, Longbin Liu, Yafei Shi, et al.Cardiovascular Therapeutics|March 30, 2010
New approaches to atrial fibrillation management: treat the patient, not the ECGArnold Pinter, Paul DorianPageof 101